Pall Biotech

Single-use systems must be designed with the end-user in mind.

Single-use biotech process equipment is already making use of technology to automate processes and the level of complexity is increasing.

Combine standardized, single-use platform technologies that can be customized to your particular process requirements, for crucial efficiency gains.

How can we reduce process risk and development times, streamline supply chains, lower costs and improve quality? Standardizing single-use.

Are we entering a new era of continuous bioprocessing? Pall’s experts discuss the opportunities and challenges ahead.

Single-use technology could help pave the way towards continuous bioprocessing.

Manufacturers have gotten to grips with the complexities of batch-based bioprocesses, but breaking into the realm of continuous bioprocessing can lead to even greater efficiency.

Traditional pharma manufacturers are already dipping their toes in the waters of continuous processing, but what about when it comes to biopharmaceuticals?

Selecting the right filter integrity test instrument is an important task.

This patented single-pass technology is an opportunity to simplify current TFF processes.

One of the major trends in pharmaceutical manufacturing over the last decade has been the replacement of traditional, reusable cleanable components by single-use disposable alternatives.

Accelerated process development through the identification ofoptimal platform solutions

The Cadence inline diafiltration (ILDF) device is designed for continuous processing, in-process buffer exchange or contaminant removal in various processes in a wide range of applications in the biopharmaceutical industry.

The following application note summarizes the advantages of coupling SPTFF with chromatography.

In this study, the Protein A mAb capture process is modeled with a focus on the benefits of multi-column chromatography vs. single column (batch) operation.

Single-use bioreactors have only been cylindrical in design, until now.